Enfermedad de Parkinson: fisiopatología y nuevos tratamientos
University of Birmingham
Birmingham, Reino UnidoPublications in collaboration with researchers from University of Birmingham (1)
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341